There is currently no text in this page. You can search for this page title in other pages, or search the related logs, but you do not have permission to create this page.
Category:CPC A61K38/177
Pages in category "CPC A61K38/177"
The following 36 pages are in this category, out of 36 total.
1
- 18554705. NOVEL ANTI-INFLAMMATORY THERAPEUTICS AND METHOD OF USE THEREOF simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18757357. A GENE THERAPY STRATEGY TO RESTORE ELECTRICAL AND CARDIAC FUNCTION, AND CARDIAC STRUCTURE, IN ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY (The Regents of the University of California)
- 19009000. ANTI-FIBROTIC SIALIDASE INHIBITOR COMPOUNDS AND METHODS OF USE (THE TEXAS A&M UNIVERSITY SYSTEM)
2
- 20250161409. Compositions Treati (PROSPERA BIOTECH, S.L.)
- 20250177483. Transmembrane Stem Cell Factor (tm-scf) Lipid Nanocarriers Methods Use Ther (BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM)
- 20250177484. Formulated And/or Co- (Nammi Therapeutics, .)
- 20250186548. Method Treating Myasthen (REMEGEN ., .)
B
C
D
H
J
M
T
- The Board of Trustees of the Leland Stanford Junior University Patent Application Trends in 2024
- The regents of the university of california (20250000945). Suppression of Neurodegeneration with Zinc Transporter Protein 7
- The Regents of The University Of California Patent Application Trends in 2024
- THE REGENTS OF THE UNIVERSITY OF CALIFORNIA Patent Application Trends in 2024
- The Regents of the University of California Patent Application Trends in 2025
- The Regents of The University Of California Patent Application Trends in 2025
- The Regents of the University of California patent applications on January 2nd, 2025
- Translate Bio, Inc. Patent Application Trends in 2024